News from collplant A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 01, 2020, 07:00 ET CollPlant Biotechnologies Reports Year End Financial Results for Fiscal Year 2019

CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company, today announced financial results for the full year ended December 31, 2019 ...


Feb 14, 2020, 07:00 ET CollPlant Biotechnologies Raising $4.45 Million in U.S. Private Placement

CollPlant (NASDAQ: CLGN) (the "Company"), a regenerative and aesthetic medicine company, announced it has entered into definitive agreements for up...


Feb 10, 2020, 07:00 ET CollPlant Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P. as Chairman of the Board of Directors

CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, today announced the appointment of Roger J. Pomerantz, M.D., F.A.C.P. to its ...


Feb 04, 2020, 07:50 ET CollPlant Launches New Corporate Website to Showcase Recent Developments in Core Business Segments

CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, today announced the launch of its updated corporate website. The new website ...


Jan 13, 2020, 08:00 ET 3D Systems and CollPlant Biotechnologies Join Forces to Accelerate Breakthroughs in Regenerative Medicine

Today, 3D Systems (NYSE: DDD) and CollPlant Biotechnologies (NASDAQ: CLGN), announced signing a joint development agreement intended to play a...


Jan 06, 2020, 07:00 ET CollPlant Partners in the Advanced Regenerative Manufacturing Institute

CollPlant (NASDAQ:CLGN), a regenerative medicine company, today announced it is now part of a new public-private ManufacturingUSA initiative, the...


Dec 19, 2019, 07:00 ET CollPlant Publishes Letter to Shareholders

CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced that Yehiel Tal, Chief Executive Officer of CollPlant Biotechnologies, has ...


Nov 29, 2019, 08:46 ET CollPlant Reports Third Quarter 2019 Financial Results and Provides Business Update

CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced financial results for the third quarter ended September 30, 2019 and...


Oct 22, 2019, 07:00 ET CollPlant CEO Yehiel Tal Appointed to Serve on International Society for Biofabrication's Industry Relations Committee

CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced the Company's Chief Executive Officer Yehiel Tal was recently appointed as ...


Oct 16, 2019, 08:00 ET CollPlant to Present at Dawson James Small Cap Growth Conference on October 29, 2019 in Florida

CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced the Company's Chief Executive Officer Yehiel Tal will present at the...


Sep 26, 2019, 07:00 ET CollPlant Reports Second Quarter 2019 Financial Results and Provides Business Update

CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced financial results for the second quarter ended June 30, 2019 and provided...


Sep 09, 2019, 07:00 ET CollPlant Biotechnologies Closes on $5.5 Million Financing

CollPlant (NASDAQ:CLGN) (the "Company"), a regenerative medicine company, announced it has closed on a total of $5.5 million in convertible loans. A...


Sep 05, 2019, 07:00 ET CollPlant Biotechnologies to Present at the 21st Annual Rodman & Renshaw Global Investment Conference

CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced that Yehiel Tal, Chief Executive Officer will be presenting at the 21st...


Sep 03, 2019, 09:00 ET CollPlant Biotechnologies Raising $5.5 Million

CollPlant (NASDAQ: CLGN) (the "Company"), a regenerative medicine company, announced it has entered into definitive agreements for up to $6.5 million ...


Aug 05, 2019, 07:00 ET CollPlant is Developing 3D-bioprinted Implants for Regeneration of Breast Tissue

CollPlant (NASDAQ: CLGN) (the "Company"), a regenerative medicine company, announced today that it is developing 3D bioprinted implants for...


Jun 20, 2019, 08:00 ET CollPlant Announces Corporate Name Change to CollPlant Biotechnologies to Better Reflect Its Business

CollPlant (NASDAQ: CLGN) (the "Company"), a regenerative medicine company, announced today that its corporate name has changed from "CollPlant...


Jun 04, 2019, 07:00 ET Clinical Results From CollPlant's Advanced Wound Care Product VergenixFG to Be Presented at European Wound Management Association Conference

CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced that the results from a clinical study conducted with its VergenixFG...


May 30, 2019, 07:57 ET CollPlant Reports First Quarter 2019 Financial Results and Provides Business Update

CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced financial results for the first quarter ended March 31, 2019 and provided...


May 28, 2019, 07:00 ET CollPlant Presents Its rhCollagen-based BioInks for 3D Bioprinting of Tissues and Organs at TERMIS Annual Meeting in Rhodes, Greece

CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced that Dr. Nadav Orr, the Company's Vice President for R&D, presented the...


May 22, 2019, 08:41 ET CollPlant Launches New HQ and R&D Center in Israel

CollPlant (NASDAQ: CLGN), a regenerative medicine company, has launched a new HQ and R&D center in Israel. CollPlant is developing, manufacturing and ...


Apr 24, 2019, 15:28 ET CollPlant Announces Publication of Study in Science Translational Medicine Showing Composite Matrix Based on rhCollagen, Ceramics and Bone Morphogenic Protein Led to Bone Growth Superior to Standard of Care

CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced the publication of a study titled, "Bone Repair with a Receptor Optimized...


Apr 23, 2019, 07:00 ET CollPlant to Present at ThinkEquity Conference on May 2, 2019 in New York City

CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced the Company will present at the ThinkEquity Conference on Thursday, May 2, ...


Apr 01, 2019, 13:14 ET CollPlant Reports Fourth Quarter and Year End 2018 Financial Results and Provides Business Update

CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced financial results for the fourth quarter and year ended December 31, 2018...


Mar 18, 2019, 08:00 ET CollPlant Renews Distribution Agreement for Its Soft Tissue Repair Product Vergenix™STR With Arthrex a World Leader in Orthopedics

CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced that it has renewed its exclusive distribution agreement with Arthrex for...


Mar 11, 2019, 07:00 ET Study Published in Wounds Journal Shows Remarkable Wound Closure Performance With CollPlant's VergenixFG in the Treatment of Chronic Wounds With a 94% Median Wound Area Reduction Within 4-weeks

CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced results from a clinical study conducted with its VergenixFG wound care...